Last reviewed · How we verify
NCT05414435
Informed Consent in Endoscopy: Read, Understood or Merely Signed?
trial testing Reading of informed consent form in Informed Consent in 232 participants. Completed in 30 April 2022.
30 April 2022
Quick facts
| Lead sponsor | Centro Hospitalar Tondela-Viseu |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 232 |
| Start date | 1 April 2021 |
| Primary completion | 30 April 2022 |
| Estimated completion | 30 April 2022 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Reading of informed consent form
Conditions studied
- Informed Consent — all drugs for Informed Consent →
- Gastrointestinal Endoscopy — all drugs for Gastrointestinal Endoscopy →
Sponsor
Centro Hospitalar Tondela-Viseu
Who can join
18 and older, any sex, with Informed Consent or Gastrointestinal Endoscopy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Informed consent form is a legal document that, ethically, should be obtained before any endoscopic procedure is performed. The main purpose of this research study is to assess the readability, comprehensibility and applicability of the new informed consent proposed by the Portuguese Society of Digestive Endoscopy as a way to standardize the information provided to patients prior to endoscopic exams.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Informed consent in endoscopy: Read, understood, or just signed?
Carvalho AC, Cardoso R, Vieira HM, Silva A. · · 2024 · PMID 41647094 · DOI 10.1016/j.igie.2024.04.001
Verify or expand the search:
- PubMed search for NCT05414435
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Informed Consent
Currently open trials in the same condition.
- NCT07303517 — AI-Driven Consent Simplification Study · recruiting
- NCT06192511 — Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening · NA · recruiting
- NCT07074925 — Video-Assisted Informed Consent for Neonatal Lumbar Puncture · NA · active not recruiting
Other Centro Hospitalar Tondela-Viseu trials
Trials by the same sponsor.
- NCT05040854 — Can we Rely on HLA to Predict Resistance to Biological Therapy in IBD Patients · unknown
- NCT06480929 — LV Thrombus Screening in Anterior STEMI: Worth it? · NA · completed
- NCT05162339 — Inflammatory Bowel Disease and Thromboembolic Events · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05414435 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centro Hospitalar Tondela-Viseu
- Last refreshed: 15 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05414435.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing